ID: ALA3403525

Max Phase: Preclinical

Molecular Formula: C20H17N3O4

Molecular Weight: 363.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(=O)c1ccc2cc(OC(=O)c3ccc(NC(=N)N)cc3)ccc2c1

Standard InChI:  InChI=1S/C20H17N3O4/c1-26-18(24)15-3-2-14-11-17(9-6-13(14)10-15)27-19(25)12-4-7-16(8-5-12)23-20(21)22/h2-11H,1H3,(H4,21,22,23)

Standard InChI Key:  DVNNDDZBSYOOIJ-UHFFFAOYSA-N

Associated Targets(Human)

Hepatocyte growth factor activator 149 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 363.37Molecular Weight (Monoisotopic): 363.1219AlogP: 3.15#Rotatable Bonds: 4
Polar Surface Area: 114.50Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 7.58CX LogP: 3.60CX LogD: 3.21
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.28Np Likeness Score: -0.40

References

1. Franco FM, Jones DE, Harris PK, Han Z, Wildman SA, Jarvis CM, Janetka JW..  (2015)  Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: Evaluation of potency and selectivity derived from distinct binding pockets.,  23  (10): [PMID:25882520] [10.1016/j.bmc.2015.03.072]

Source